Liver immune-related adverse effects of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors: A propensity score matched study with competing risk analyses Research Letter

  

Authors:	Zhou, J.; Chau, Y. L. A.; Yoo, J. W.; Lee, S.; Ng, K.; Dee, E. C.; Liu, T.; Wai, A. K. C.; Zhang, Q.; Tse, G.
Title:	Liver immune-related adverse effects of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors: A propensity score matched study with competing risk analyses
Keywords:	apoptosis; lung neoplasms; risk assessment; lung tumor; liver; ligand; ligands; adverse drug reaction; programmed death 1 ligand 1; programmed death 1 receptor; propensity score; humans; human; programmed cell death 1 receptor; drug-related side effects and adverse reactions; b7-h1 antigen
Journal Title:	Clinical Oncology
Volume:	34
Issue:	7
ISSN:	0936-6555
Publisher:	Elsevier Science, Inc.
Date Published:	2022-07-01
Start Page:	e316
End Page:	e317
Language:	English
DOI:	10.1016/j.clon.2022.03.006
PUBMED:	35321832
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85131828161&doi=10.1016%2fj.clon.2022.03.006&partnerID=40&md5=026987e14e4ae57922a3bcf4b3f9a050
Notes:	Letter -- Export Date: 1 July 2022 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/195478